<table xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>Table 13 Established and Other Potentially Significant Drug Interactions</caption>
<col></col>
<col></col>
<col></col>
<thead>
<tr>
<td colspan="1" stylecode="     Botrule          Toprule         Lrule          Rrule     " valign="top"> <content stylecode="bold">Concomitant </content>
<content stylecode="bold">Drug</content>
<content stylecode="bold">
<br/>
</content>
</td>
<td colspan="1" stylecode="     Botrule          Toprule         Lrule          Rrule     " valign="top"> <content stylecode="bold">Effect </content>
<content stylecode="bold">on </content>
<content stylecode="bold">Concentration </content>
<content stylecode="bold">of </content>
<content stylecode="bold">Lamotrigine </content>
<content stylecode="bold">or </content>
<content stylecode="bold">Concomitant </content>
<content stylecode="bold">Drug</content>
<content stylecode="bold">
<br/>
</content>
</td>
<td colspan="1" stylecode="     Botrule          Toprule         Lrule          Rrule     " valign="top"> <content stylecode="bold">Clinical </content>
<content stylecode="bold">Comment</content>
<content stylecode="bold">
<br/>
</content>
</td>
</tr>
</thead>
<tfoot>
<tr>
<td colspan="3"> <paragraph>↓ = Decreased (induces lamotrigine glucuronidation).<br/>
</paragraph>
</td>
</tr>
<tr>
<td colspan="3"> <paragraph>↑ =  Increased (inhibits lamotrigine glucuronidation).<br/>
</paragraph>
</td>
</tr>
<tr>
<td colspan="3"> <paragraph>? = Conflicting data.<br/>
</paragraph>
</td>
</tr>
</tfoot>
<tbody>
<tr>
<td stylecode="     Toprule         Lrule          Rrule     " valign="top"> Estrogen-containing oral contraceptive preparations containing 30 mcg ethinylestradiol and 150 mcg levonorgestrel<br/>
</td>
<td stylecode="     Botrule          Toprule         Lrule          Rrule     " valign="top"> ↓ lamotrigine<br/>
</td>
<td stylecode="     Botrule          Toprule         Lrule          Rrule     " valign="top"> Decreased lamotrigine concentrations approximately 50%.<br/>
</td>
</tr>
<tr>
<td stylecode="     Botrule         Lrule          Rrule     "> <br/>
</td>
<td stylecode="     Botrule          Toprule         Lrule          Rrule     " valign="top"> ↓ levonorgestrel<br/>
</td>
<td stylecode="     Botrule          Toprule         Lrule          Rrule     " valign="top"> Decrease in levonorgestrel component by 19%.<br/>
</td>
</tr>
<tr>
<td stylecode="     Toprule         Lrule          Rrule     " valign="top"> Carbamazepine and epoxide<br/>
</td>
<td stylecode="     Botrule          Toprule         Lrule          Rrule     " valign="top"> ↓ lamotrigine<br/>
</td>
<td stylecode="     Botrule          Toprule         Lrule          Rrule     " valign="top"> Addition of carbamazepine decreases lamotrigine concentration approximately 40%.<br/>
</td>
</tr>
<tr>
<td stylecode="     Botrule         Lrule          Rrule     "> <br/>
</td>
<td stylecode="     Botrule          Toprule         Lrule          Rrule     " valign="top"> ? Carbamazepine <br/> epoxide<br/>
</td>
<td stylecode="     Botrule          Toprule         Lrule          Rrule     " valign="top"> May increase <br/>Carbamazepine epoxide levels.<br/>
</td>
</tr>
<tr>
<td stylecode="     Botrule          Toprule         Lrule          Rrule     " valign="top"> Lopinavir/ritonavir <br/>
</td>
<td stylecode="     Botrule          Toprule         Lrule          Rrule     " valign="top"> ↓ lamotrigine <br/>
</td>
<td stylecode="     Botrule          Toprule         Lrule          Rrule     " valign="top"> Decreased lamotrigine concentration approximately 50%. <br/>
</td>
</tr>
<tr>
<td stylecode="     Botrule          Toprule         Lrule          Rrule     " valign="top"> Atazanavir/ritonavir <br/>
</td>
<td stylecode="     Botrule          Toprule         Lrule          Rrule     " valign="top"> ↓ lamotrigine <br/>
</td>
<td stylecode="     Botrule          Toprule         Lrule          Rrule     " valign="top"> Decreased lamotrigine AUC approximately 32%. <br/>
</td>
</tr>
<tr>
<td stylecode="     Botrule          Toprule         Lrule          Rrule     " valign="top"> Phenobarbital/Primidone<br/>
</td>
<td stylecode="     Botrule          Toprule         Lrule          Rrule     " valign="top"> ↓ lamotrigine<br/>
</td>
<td stylecode="     Botrule          Toprule         Lrule          Rrule     " valign="top"> Decreased lamotrigine concentration approximately 40%.<br/>
</td>
</tr>
<tr>
<td stylecode="     Botrule          Toprule         Lrule          Rrule     " valign="top"> Phenytoin<br/>
</td>
<td stylecode="     Botrule          Toprule         Lrule          Rrule     " valign="top"> ↓ lamotrigine<br/>
</td>
<td stylecode="     Botrule          Toprule         Lrule          Rrule     " valign="top"> Decreased lamotrigine concentration approximately 40%.<br/>
</td>
</tr>
<tr>
<td stylecode="     Botrule          Toprule         Lrule          Rrule     " valign="top"> Rifampin<br/>
</td>
<td stylecode="     Botrule          Toprule         Lrule          Rrule     " valign="top"> ↓ lamotrigine<br/>
</td>
<td stylecode="     Botrule          Toprule         Lrule          Rrule     " valign="top"> Decreased lamotrigine AUC approximately 40%.<br/>
</td>
</tr>
<tr>
<td stylecode="     Botrule          Toprule         Lrule          Rrule     " valign="top"> Valproate<br/>
</td>
<td stylecode="     Botrule          Toprule         Lrule          Rrule     " valign="top"> ↑ lamotrigine<br/>
</td>
<td stylecode="     Botrule          Toprule         Lrule          Rrule     " valign="top"> Increased lamotrigine concentrations slightly more than 2-fold.<br/>
</td>
</tr>
<tr>
<td stylecode="     Botrule          Toprule         Lrule          Rrule     " valign="top"> <br/>
</td>
<td stylecode="     Botrule          Toprule         Lrule          Rrule     " valign="top"> ? valproate<br/>
</td>
<td stylecode="     Botrule          Toprule         Lrule          Rrule     " valign="top"> There are conflicting study results regarding effect of lamotrigine on valproate concentrations: 1) a mean 25% decrease in valproate concentrations in healthy volunteers, 2) no change in valproate concentrations in controlled clinical trials in patients with epilepsy. <br/>
</td>
</tr>
</tbody>
</table>